sii
Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla-
By PTI PUNE: Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get ...
Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr; 7 nabbed-
By ANI PUNE: In a major breakthrough, the Pune Police said they have arrested seven accused in the cheating case in ...
SII stopped Covishield production in Dec 2021; Poonawalla; claims are no takers for booster shots –
By PTI PUNE: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped ...
SII seeks nod to export 32.4 lakh doses of its Covid vaccine Covovax to US-
By PTI NEW DELHI: The Serum Institute has sought the Centre’s approval to export 32.4 lakh doses of the COVID-19 ...
Panel for emergency use approval to SII vaccination for 7-11 age group-
By Express News Service NEW DELHI: An expert panel advising the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...
SII lowers each dose of Covovax jab from Rs 900 to Rs 225 excluding taxes-
By PTI NEW DELHI: A day after its Covid shot Covovax was included on the CoWIN portal for inoculation of ...
SII urges Mandaviya to reduce gap between 2nd, precaution dose of Covishield from 9 to 3 months-
By PTI NEW DELHI: Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the ...
SII applies for full market authorisation of Covishield as supplies of vaccine exceeded 125 crore do-
By PTI NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawala on Friday said it has applied to Indian ...
CDSCO panel seeks local clinical trial data from SII for approval of Covishield as booster dose-
By PTI NEW DELHI: An expert panel of India’s central drug authority which reviewed Serum Institute’s application for approval of ...
SII urges government to fast-track movement of increasing Covishield stock-
By PTI NEW DELHI: Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties ...
